Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Respiri engages Chinese production to up asthma device manufacturing
    • News

    Respiri engages Chinese production to up asthma device manufacturing

    Medtech company Respiri (ASX: RSH) has continued its long path towards commercialisation of its asthma diagnostics device ‘wheezo’, having entered into a global manufacturing agreement with Entech Electronics for 12,000 devices.  The agreement will see Entech manufacture the devices from their facilities in Shenzen, China. The order placed is for significantly more devices than the

    Read More
    Public
  • Italian Hospital to commence 3-month trial of Vection’s augmented reality
    • News

    Italian Hospital to commence 3-month trial of Vection’s augmented reality

    Technology we’ve really only seen in the Ironman movies could soon become a reality with Vection Technologies (ASX: VR1) set to have it’s augmented reality technology trialed by a hospital in Italy.  The trial will focus on two augmented reality healthcare solutions developed by Vection. The first will enable surgeons to view data fields from

    Read More
    Public
  • Emerge Gaming increases global reach with Microsoft partnership
    • News

    Emerge Gaming increases global reach with Microsoft partnership

    Gaming tech and eSports company Emerge Gaming (ASX: EM1) is set to gain access to mass distribution having been appointed by Microsoft as an Independent Software Vendor (ISV) which will secure access to industry-leading technology and new customers in 61 countries.  The partnership will enable Emerge Gaming to access Microsoft’s hardware services which drive modern

    Read More
    Public
  • Invictus Energy targets Zimbabwe after Mobil abandon large undrilled oil and gas prospect
    • Opinion

    Invictus Energy targets Zimbabwe after Mobil abandon large undrilled oil and gas prospect

    Back in the early 1990s, Mobil was exploring for oil in Zimbabwe when it came across large hydrocarbon resources in the Cabora Bassa Basin. The petroleum giant explored over an area extending all the way from Victorian Falls in the west of the country through to the Cabora Bassa Basin in the east. It identified

    Read More
    Public
  • Fund Manager thoughts on a COVID-19 vaccine and near-term outlook
    • Opinion

    Fund Manager thoughts on a COVID-19 vaccine and near-term outlook

    BanyanTree Investment Group was recently featured on Ausbiz where Fund Manager Zach Riaz offered his views on the recent market correction and the periphery services that will see increased commercial activity once a COVID-19 vaccine is developed. Here are this thoughts. Vaccine timeline Clearly this will have a material impact on investor sentiment, the health

    Read More
    Public
  • Entrepreneur eyes virtual fast food to counter virtual fitness boom
    • Satire

    Entrepreneur eyes virtual fast food to counter virtual fitness boom

    With populations locked up in their homes, there has been a spike in virtual fitness which has opened the door for entrepreneur Hugh Honey’s new venture that will enable lazy Australians to experience all the pleasures of junk food and indulgence within the comfort of their homes. The idea came to Honey after seeing news

    Read More
    Public
  • «
  • ‹
  • 571
  • 572
  • 573
  • 574
  • 575
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.